Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 3, 2025
Reporting Period: Events occurring on March 3, 2025, and March 4, 2025.
This filing announces the Company's "Uplisting" to the Nasdaq Global Market and associated corporate governance updates.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and listing status rather than financial performance.
Material Changes
- Nasdaq Uplisting: The Company received approval from the Nasdaq Listing Qualifications Staff on March 3, 2025. Common stock is scheduled to begin trading on the Nasdaq Global Market on March 7, 2025, under the ticker symbol SNWV.
- Bylaw Amendments: On March 4, 2025, the Board approved Amended and Restated Bylaws. Key changes include:
- Adjusting the stockholder proposal notice window to 90-120 days prior to the annual meeting anniversary.
- Prohibiting stockholders from calling special meetings.
- Requiring non-management proxy forms to use a color other than white.
- Eliminating the requirement to make stockholder lists available for examination at meetings.
- Increasing the maximum authorized number of directors from nine to ten.
- Designating the Eighth Judicial District Court of Clark County, Nevada, as the exclusive forum for disputes.
- Code of Ethics: A new Code of Business Conduct and Ethics was approved on March 4, 2025.
Guidance, Outlook, and Risks
Outlook: The Company expects trading to commence on March 7, 2025. The filing includes forward-looking statements regarding future financial results, production expectations, and business development plans.
Risks and Contingencies: The Company cautions that actual results may differ materially from projections due to risks including regulatory oversight, capital resource management, and competition. The Company undertakes no obligation to update forward-looking statements.
Investor Verification Checklist
- Verify the commencement of trading on the Nasdaq Global Market under ticker SNWV on March 7, 2025.
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.1) to understand restrictions on stockholder rights, specifically regarding special meetings and proxy solicitation.
- Confirm the availability of the new Code of Business Conduct and Ethics on the Company's investor relations website.
- Monitor subsequent filings for the first financial results reported under the new listing status.